-
1كتاب
المؤلفون: Aktaş, Nimet
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/ İç Hastalıkları Anabilim Dalı/Nefroloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., orcid:0000-0002-0342-9692, orcid:0000-0003-4607-9220, Oruç, Ayşegül, Ayar, Yavuz, Vuruşkan, Berna Aytaç, Yıldız, Abdülmecit, Yavuz, Mahmut, Güllülü, Mustafa, Dilek, Kamil, Ersoy, Alparslan, AAH-4002-2021, O-9948-2015, AAH-9746-2021, AGF-0767-2022, GSE-0029-2022, 55133912100, 55860143300, 56527372000, 56256977500, 7006244754, 6602684544, 56005080200, 35612977100
مصطلحات موضوعية: Urology & nephrology, Complement inhibitor eculizumab, Adult, Antibodies, monoclonal, humanized, Atypical hemolytic uremic syndrome, Chemical and drug induced liver injury, Humans, Male, Aminotransferase, Amlodipine, Carvedilol, Creatinine, Eculizumab, Lactate dehydrogenase, Methyldopa, Ramipril, Monoclonal antibody, Blood pressure regulation, Blood smear, Case report, Clinical article, Creatinine blood level, Disease classification, Drug withdrawal, Echography, Fatty liver, Headache, Hemolytic uremic syndrome
وصف الملف: application/pdf
العلاقة: Makale - Uluslararası Hakemli Dergi; Nefrologia; Sanayi; Oruç, A. vd. (2018). ''Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome''. Nefrologia, 38(4), 448-450.; https://doi.org/10.1016/j.nefroe.2018.04.004Test; https://www.sciencedirect.com/science/article/pii/S2013251418300622Test; http://hdl.handle.net/11452/34810Test; 000439099700019; 2-s2.0-85049994526; 448; 450; 38
الإتاحة: https://doi.org/10.1016/j.nefroe.2018.04.004Test
http://hdl.handle.net/11452/34810Test
https://www.sciencedirect.com/science/article/pii/S2013251418300622Test -
2كتاب
المؤلفون: Aktaş, Nimet
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/ İç Hastalıkları Anabilim Dalı/Nefroloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., orcid:0000-0002-0342-9692, orcid:0000-0003-4607-9220, Oruç, Ayşegül, Ayar, Yavuz, Vuruşkan, Berna Aytaç, Yıldız, Abdülmecit, Yavuz, Mahmut, Güllülü, Mustafa, Dilek, Kamil, Ersoy, Alparslan, AAH-4002-2021, O-9948-2015, AAH-9746-2021, AGF-0767-2022, GSE-0029-2022, 55133912100, 55860143300, 56527372000, 56256977500, 7006244754, 6602684544, 56005080200, 35612977100
مصطلحات موضوعية: Urology & nephrology, Complement inhibitor eculizumab, Adult, Antibodies, monoclonal, humanized, Atypical hemolytic uremic syndrome, Chemical and drug induced liver injury, Humans, Male, Aminotransferase, Amlodipine, Carvedilol, Creatinine, Eculizumab, Lactate dehydrogenase, Methyldopa, Ramipril, Monoclonal antibody, Blood pressure regulation, Blood smear, Case report, Clinical article, Creatinine blood level, Disease classification, Drug withdrawal, Echography, Fatty liver, Headache, Hemolytic uremic syndrome
وصف الملف: application/pdf
العلاقة: Makale - Uluslararası Hakemli Dergi; Nefrologia; Sanayi; Oruç, A. vd. (2018). ''Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome''. Nefrologia, 38(4), 448-450.; https://doi.org/10.1016/j.nefroe.2018.04.004Test; https://www.sciencedirect.com/science/article/pii/S2013251418300622Test; http://hdl.handle.net/11452/34810Test; 000439099700019; 2-s2.0-85049994526; 448; 450; 38
الإتاحة: https://doi.org/10.1016/j.nefroe.2018.04.004Test
http://hdl.handle.net/11452/34810Test
https://www.sciencedirect.com/science/article/pii/S2013251418300622Test